ArticleEuropean respiratory review : an official journal of the European Respiratory Society2013
Personalised medicine for cystic fibrosis: treating the basic defect.
Article in European respiratory review : an official journal of the European Respiratory Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis.Scientific reports · 2019Pooled it
- Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators.Acta paediatrica (Oslo, Norway : 1992) · 2026Observational
- The Impact of Physical Activity on Clinical Outcomes in Children with Cystic Fibrosis: A Narrative Review.Children (Basel, Switzerland) · 2025Review
- A uniquely efficacious type of CFTR corrector with complementary mode of action.Science advances · 2024Article
- Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy.The Lancet. Respiratory medicine · 2023Review
- The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation.Clinics in chest medicine · 2022Review
- Effectiveness of Physical Exercise Interventions on Pulmonary Function and Physical Fitness in Children and Adults with Cystic Fibrosis: A Systematic Review with Meta-Analysis.Healthcare (Basel, Switzerland) · 2022Review
- A new era for people with cystic fibrosis.European journal of pediatrics · 2021Review
- Optical Nanosensors forAnalytical methods : advancing methods and applications · 2020Article
- Comparison of US Federal and Foundation Funding of Research for Sickle Cell Disease and Cystic Fibrosis and Factors Associated With Research Productivity.JAMA network open · 2020Article
- Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis-Learning from Other Diseases.Genes · 2019Review
- Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.Vaccines · 2018Review
- [Chronic Pseudomonas aeruginosa airway colonization in cystic fibrosis patients : Prevention concepts].Der Internist · 2017Review
- An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosis.Patient preference and adherence · 2017Article
- Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".Patient preference and adherence · 2016Article
- Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2013Review
- Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation.European respiratory review : an official journal of the European Respiratory Society · 2013Review
- The impact of personalised therapies on respiratory medicine.European respiratory review : an official journal of the European Respiratory Society · 2013Article
- Mathematical models of cystic fibrosis as a systemic disease.WIREs mechanisms of diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.